A detailed history of Onefund, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Onefund, LLC holds 5,324 shares of BMY stock, worth $311,454. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,324
Previous 5,317 0.13%
Holding current value
$311,454
Previous $221 Million 24.75%
% of portfolio
0.28%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $277 - $362
7 Added 0.13%
5,324 $275 Million
Q2 2024

Nov 13, 2024

BUY
$40.25 - $52.99 $3,220 - $4,239
80 Added 1.53%
5,317 $221 Million
Q1 2024

Nov 13, 2024

SELL
$47.98 - $54.4 $6,957 - $7,888
-145 Reduced 2.69%
5,237 $278 Million
Q4 2023

Nov 13, 2024

BUY
$48.48 - $57.85 $260,919 - $311,348
5,382 New
5,382 $276 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Onefund, LLC Portfolio

Follow Onefund, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Onefund, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Onefund, LLC with notifications on news.